Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
March 10 2015 - 4:00PM
Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today
announced that its Board of Directors has declared a quarterly cash
dividend payment on the Company's 10.50% Series E Convertible
Preferred Stock (the "Series E Preferred Stock").
The quarterly dividend on the Series E Preferred Stock is
payable on April 1, 2015 to holders of record at the close of
business on March 20, 2015.
The quarterly dividend payment on the Series E Preferred Stock
will be $0.65625 per share, which is equivalent to an annualized
10.50% per share, based on the $25.00 per share stated liquidation
preference, accruing from January 1, 2015 through March 31, 2015.
The Series E Preferred Stock is listed on the NASDAQ Capital Market
and trades under the ticker symbol "PPHMP".
About Peregrine Pharmaceuticals, Inc.
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company
with a pipeline of novel drug candidates in clinical trials for the
treatment and diagnosis of cancer. The company's lead
immuno-oncology candidate, bavituximab, is in Phase III development
for the treatment of second-line non-small lung cancer (the
"SUNRISE trial") along with several investigator-sponsored trials
evaluating other treatment combinations and additional oncology
indications. The company is also advancing a molecular imaging
agent, 124I-PGN650, in an exploratory clinical trial for the
imaging of multiple solid tumor types. Peregrine also has in-house
cGMP manufacturing capabilities through its wholly-owned subsidiary
Avid Bioservices, Inc. (www.avidbio.com), which provides
development and biomanufacturing services for both Peregrine and
third-party customers. Additional information about Peregrine can
be found at www.peregrineinc.com.
CONTACT: Christopher Keenan
Peregrine Pharmaceuticals, Inc.
(800) 987-8256
info@peregrineinc.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Sep 2023 to Sep 2024